✦ LIBER ✦

Antiphospholipid antibodies are common in patients referred for percutaneous patent foramen ovale closure

✍ Scribed by Stephen M. Dodge; Kathryn Hassell; C. Alan Anderson; Jana Keller; Bertron Groves; John D. Carroll

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 78 KB
Volume: 61
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.10754

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Implantation of a second closure device

Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale

✍ Markus Schwerzmann; Stephan Windecker; Andreas Wahl; Krassen Nedeltchev; Heinric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

## Abstract Percutaneous closure of patent foramen ovale (PFO) in patients with presumed paradoxical embolism yields complete occlusion in > 90% of patients using contemporary closure devices. Patients with a residual shunt after percutaneous PFO closure have been found at increased risk for recurr

Instant percutaneous closure of patent f

Instant percutaneous closure of patent foramen ovale in patients with acute myocardial infarction and normal coronary arteries

✍ Vivek K. Mehan; Andreas Wahl; Nazan Walpoth; Bernhard Meier 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

Should we be using bilateral carotid dis

Should we be using bilateral carotid distal protection devices during the percutaneous closure of patent foramen ovale in patients with a history of paradoxical embolus?

✍ Gail Richardson; Thomas R. Keeble; Martin T. Rothman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 3 views